Navigation Links
Edwards Lifesciences Announces Retirement of Director Vernon Loucks
Date:4/16/2008

IRVINE, Calif., April 16 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: EW), a world leader in the products and technologies to treat advanced cardiovascular disease, announced today that Vernon R. Loucks Jr. is retiring from the company's board of directors, effective May 31, 2008.

Loucks, who is chairman of the Aethena Group, LLC, has been a director of Edwards since 2000, when the company was spun off from Baxter International Inc. as an independent, publicly-held corporation. Loucks previously served as Baxter's chairman and CEO.

"I want to express my sincere gratitude to Vern for his many contributions to Edwards both prior to and since our spin-off," said Michael A. Mussallem, Edwards' chairman and CEO. "He has been an exceptional advisor and significant partner to Edwards over the years. Vern's experience and perspective have been valuable to me professionally and personally, and I want to thank him for his commitment to Edwards."

About Edwards Lifesciences

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards treats advanced cardiovascular disease with its market-leading heart valve therapies, and critical care and vascular technologies. In 2008, Edwards celebrates 50 years of partnering with clinicians to develop life-saving innovations. The company's global brands, which are sold in approximately 100 countries, include CardioVations, Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at http://www.edwards.com.

Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences, the stylized E logo, CardioVations, Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.


'/>"/>
SOURCE Edwards Lifesciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Edwards Lifesciences to Host Earnings Conference Call on April 22, 2008
2. Optimal Readings Appoints Operations Veteran Rita Edwards as SVP Clinical Operations
3. Edwards Lifesciences Chairman and CEO Adopts New 10b5-1 Stock Trading Plan to Replace Recently Expired Plan
4. Edwards Lifesciences to Present at the Citi 5th Annual Small and Mid-Cap Conference
5. Edwards Lifesciences to Present at the Cowen and Company Annual Healthcare Conference
6. Edwards Lifesciences Initiates Patent Infringement Litigation Against CoreValve in the U.S.
7. Edwards Lifesciences Reports Strong Fourth Quarter Sales
8. Edwards Lifesciences Completes Sale of LifeStent Product Line to Bard
9. Edwards Lifesciences to Present at the Southern California Investor Conference
10. Edwards Lifesciences Announces Schedule of Activities at TCT 2007
11. Edwards Lifesciences to Host Earnings Conference Call on October 22, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Appleton, WI (PRWEB) , ... March 28, 2017 ... ... how self-funded health plans work, the Self-Funding Success website has recently developed and ... about Self-Funded Health Plans ” was created based on common inquiries the site’s ...
(Date:3/28/2017)... CA (PRWEB) , ... March 28, 2017 , ... ... Carson Liu of SkyLex Advanced Surgical, Inc. is thrilled to offer the recently ... balloon procedure, and this procedure adds to SkyLex Advanced Surgical’s already comprehensive ...
(Date:3/28/2017)... ... March 28, 2017 , ... Oily skin is a common and unwelcomed occurrence in people of ... a lot to offer to the discussion of dealing with excess skin oil. “Oily skin ... many home remedies that can help remove the oily shine while keeping the skin fresh ...
(Date:3/27/2017)... ... March 27, 2017 , ... New patients who have sleep apnea ... with or without a referral. Sleep apnea is often left untreated because patients are ... headaches and chronic snoring. , Dr. Braasch seeks to raise awareness of sleep ...
(Date:3/27/2017)... Philadelphia PA and London UK (PRWEB) , ... ... ... have the speed, agility and ability to gain site attention and engagement over ... DrugDev educational webinar will discuss how partnering with the ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... SAN DIEGO and VANCOUVER, British Columbia, March 27, ... SPHS ) (the "Company" or "Sophiris"), a clinical ... treatment of patients with urological diseases, today reported ... and key corporate highlights. Key ... in Clinical Development for Localized Prostate Cancer. During ...
(Date:3/27/2017)... , March 27, 2017 /PRNewswire/ - INVICTUS MD ... IVITF; FRA: 8IS) Invictus MD is pleased to announce ... shares for trading on the TSX Venture Exchange.  ... TSXV follows a year of significant achievements for Invictus-MD. ... successful test crops at AB Laboratories Inc. ("AB Labs"), ...
(Date:3/27/2017)... , March 27, 2017 The ... reach USD 16.0 billion by 2025, according to a ... prevalence of chronic diseases is anticipated to be responsible ... which thereby widens the scope for growth during the ... bariatric population, which is highly susceptible to chronic diseases, ...
Breaking Medicine Technology: